Abstract: The invention relates to a method for the purification of aniline, comprising the following steps: a) providing a raw aniline fraction; b) extracting the raw aniline fraction with an aqueous extractant containing, in relation to the total mass of the aqueous extractant, an alkali metal hydroxide in a concentration range from 0.009 to 2.05 mass % and an alkali metal salt that is different from an alkali metal hydroxide in a concentration range from 2.40 to 25.0 mass %, wherein an organic aniline phase and an aqueous amino phenolate phase are obtained after a phase separation; c) distilling the organic aniline phase from step b), obtaining a flow of purified aniline, a gaseous flow that boils at a lower temperature than aniline and containing organic impurities, and a liquid flow that boils at a higher temperature than aniline and containing organic impurities and aniline.

Abstract: The invention relates to a method for continuous production of nitrobenzene by means of nitration of benzene with nitric acid and sulfuric acid, in which load change (i.e. a reduction or increase in the quantity of nitric acid supplied to the process per time interval) is particularly advantageously developed. The invention particularly relates to a method in which, in the case of a load reduction, the ratio of the masses of benzene and nitric acid supplied per time interval is significantly increased compared to said ratio before the load change and/or the ratio of the masses of nitric acid and sulfuric acid supplied per time interval is significantly reduced compared to said ratio before the load change. In the event of a load increase, the reverse is carried out.

Abstract: The invention relates to a method for continuous production of nitrobenzene by means of nitration of benzene with nitric acid and sulfuric acid, in which load change (i.e. a reduction or increase in the quantity of nitric acid supplied to the process per time interval) is particularly advantageously developed. The invention particularly relates to a method in which, in the case of a load reduction, the ratio of the masses of benzene and nitric acid supplied per time interval is significantly increased compared to said ratio before the load change and/or the ratio of the masses of nitric acid and sulfuric acid supplied per time interval is significantly reduced compared to said ratio before the load change. In the event of a load increase, the reverse is carried out.

Abstract: Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

Abstract: Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

Abstract: Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

Abstract: The present invention provides methods for inhibiting growth and proliferation of HIF pathway proficient cells by administering GLUT1 inhibitors of the invention to HIF pathway proficient cells.

Abstract: Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

Abstract: The present invention provides methods for inhibiting growth and proliferation of HIF pathway proficient cells by administering GLUT1 inhibitors of the invention to HIF pathway proficient cells.

Abstract: Short hairpin RNA (shRNA) interference therapy targeting hypoxia inducible factor—lot (HIF-1 ?) prolyl-4-hydroxylase protein (HIF-PHD2) is used for treatment of myocardial ischemia. This treatment can be followed noninvasively by molecular imaging. Provided are compositions comprising novel vectors encoding shRNA targeting the HIF-1? and asparaginyl hydroxylase genes. The vectors encoding shRNA are also useful for the treatment of cardiac diseases, peripheral vascular diseases and decubitis ulcers.

Abstract: Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

Abstract: Provided are certain heteroaryl benzamides, compositions, and methods of their manufacture and use.

Abstract: Short hairpin RNA (shRNA) interference therapy targeting hypoxia inducible factor—lot (HIF-1 ?) prolyl-4-hydroxylase protein (HIF-PHD2) is used for treatment of myocardial ischemia. This treatment can be followed noninvasively by molecular imaging. Provided are compositions comprising novel vectors encoding shRNA targeting the HIF-1? and asparaginyl hydroxylase genes. The vectors encoding shRNA are also useful for the treatment of cardiac diseases, peripheral vascular diseases and decubitis ulcers.

Abstract: Provided herein are novel heteroaryl compounds, compositions comprising the compounds, and methods of treatment or prevention comprising administration of the compounds. The compounds are effective in the targeting of cells defective in the von Hippel-Lindau gene and in inducing autophagic cell death. The methods are directed to treating or preventing diseases such as cancer, and in particular cancers resulting from von Hippel-Lindau disease. The compounds of the invention may be administered in combination with another therapeutic agent.

Abstract: An adapter having a front face with a flange portion and a centrally located opening. The opening has an inner dimension sized to accept at least a front face of a wiring device and the flange has an outer dimension sized to fit at least within an opening of a front face of a wall plate. The flange portion has a vertical surface contour along a vertical direction of the flange and a horizontal surface contour along a horizontal direction of the flange such that, when the adapter is installed, the contours of the flange result in a smooth transition from the wiring device to the wall plate.